Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma

CONCLUSION: This study shows that treatment with doxorubicin is associated with increased BC risk in both adolescent and adult HL survivors. Our results have implications for BC surveillance guidelines for HL survivors and treatment strategies for patients with newly diagnosed HL.PMID:38359378 | DOI:10.1200/JCO.23.01386

Source: Clinical Breast Cancer - February 15, 2024 Category: Cancer & Oncology Authors: Suzanne I M Neppelenbroek Yvonne M Geurts Berthe M P Aleman Pieternella J Lugtenburg Saskia E Rademakers Roel J de Weijer Maaike G A Schippers Bastiaan D P Ta Wouter J Plattel Jos ée M Zijlstra Richard W M van der Maazen Marten R Nijziel Francisca Ong Er Source Type: research